CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new metallodrugs for cancer treatment that target multiple pathways, addressing the limitations of single-target therapies. By combining inorganic chemistry with molecular biology, the project seeks to understand how these drugs can effectively induce cancer cell death while minimizing side…
The past decade has seen substantial advances in our understanding of cancer molecular biology and the technologies available to study it, emphasising the importance of the molecular mechanisms of carcinogenesis in cancer research.
We now face having to therapeutically aim for many less common targets rather than a few all-cancer present targets.
Effective single molecular targets therapies are generally not sufficient to elicit durable clinical responses and the development of drug resistance i…
FUNDACION IMDEA NANOCIENCIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
